SCM
ATXS

Sio Capital Management’s Astria Therapeutics ATXS Stock Holding History

Sio Capital Management’s Portfolio ATXS Stock Details ATXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-318,256
Closed -$1.71M – 55
2025
Q2 		$1.71M Buy
318,256
+3,151
+1% +$15.3K 0.65% 34
2025
Q1 		$1.68M Sell
315,105
-189,782
-38% -$1.33M 0.5% 36
2024
Q4 		$4.51M Hold
504,887
– – 1.27% 25
2024
Q3 		$5.56M Sell
504,887
-5,380
-1% -$59.8K 2.2% 17
2024
Q2 		$4.64M Buy
510,267
+100,000
+24% +$976K 1.26% 18
2024
Q1 		$5.77M Buy
+410,267
New +$5.11M 1.72% 18

Other funds holding ATXS

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Sio Capital Management's ATXS Position: Q3 2025 in Review

Sio Capital Management sold out of Astria Therapeutics (ATXS) in Q3 2025, closing a stake of 318,256 shares — an estimated $1.71M sold.

Sio Capital Management first reported a position in ATXS in Q1 2024 and held it in 6 quarters. The position peaked at $5.77M in Q1 2024. 115 funds tracked by Wall St. Rank hold ATXS as of Q3 2025.

  • Sio Capital Management reported no remaining Astria Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Sio Capital Management sold 318,256 Astria Therapeutics shares in Q3 2025, an estimated $1.71M.
  • Sio Capital Management first reported a position in Astria Therapeutics in Q1 2024 and held it in 6 quarters.
  • Sio Capital Management's Astria Therapeutics position peaked at $5.77M in Q1 2024.
  • 115 funds tracked by Wall St. Rank held Astria Therapeutics as of Q3 2025.

Based on Sio Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.